Seeking Alpha

StemCells (STEM) partners with Edinburgh, UK-based R Biomedical to develop and commercialize a...

StemCells (STEM) partners with Edinburgh, UK-based R Biomedical to develop and commercialize a range of cell lines and reagents to be used in stem cell-based research for regenerative medicine applications. The first product under the partnership, an "ultra-primary" human fibroblast cell line from which researchers can generate iPS cell lines, was launched today under STEM's SC Proven brand.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|